Novolog and Dynacirc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Novolog (insulin aspart recombinant) and Dynacirc (isradipine). Common drug interactions include hemiparesis among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Novolog and Dynacirc. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

22 people who take Novolog and Dynacirc together, and have interactions are studied.

Novolog and Dynacirc drug interactions.

What are the common drug interactions of Novolog and Dynacirc, by gender? *:

female:

  1. Hemiparesis (weakness on one side of the body)
  2. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Oedema peripheral (superficial swelling)
  5. Pain
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Peripheral vascular disorder
  8. Abdominal discomfort
  9. Abscess jaw (tooth abscess or root abscess)
  10. Abscess neck (neck abscesses)

male:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Anaemia (lack of blood)
  4. Angioedema (rapid swelling of the dermis)
  5. Angiomyolipoma (most common benign tumour of the kidney)
  6. Anisocytosis (patient's red blood cells are of unequal size)
  7. Anxiety
  8. Arrhythmia (irregular heartbeat)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Asthenia (weakness)

What are the common drug interactions of Novolog and Dynacirc, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthma
  2. Blindness
  3. Blood glucose increased
  4. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  5. Depression
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  8. Drug ineffective
  9. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  10. Fatigue (feeling of tiredness)

40-49:

  1. Abdominal pain
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Gastrointestinal pain
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema peripheral (superficial swelling)
  7. Pain in extremity
  8. Vomiting

50-59:

  1. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  2. Peripheral vascular disorder
  3. Asthenia (weakness)
  4. Hypertension (high blood pressure)
  5. Medical device complication
  6. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Post procedural complication
  9. Hypertensive emergency
  10. Depressed mood

60+:

  1. Blood glucose increased
  2. Headache (pain in head)
  3. Angiomyolipoma (most common benign tumour of the kidney)
  4. Anisocytosis (patient's red blood cells are of unequal size)
  5. Anxiety
  6. Arrhythmia (irregular heartbeat)
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Asthenia (weakness)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Back pain

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 36.36%
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 22.73%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 22.73%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 13.64%
  5. Indigestion: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and Dynacirc?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Novolog and Dynacirc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dynacirc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novolog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dynacirc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant and isradipine (the active ingredients of Novolog and Dynacirc, respectively), and Novolog and Dynacirc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: